partnering with patient in research is all about.
Thromb Res [Internet]. 2017;150:113–20.
Disponible en: http://dx.doi.org/10.1016/j.
thromres.2016.10.029
30. Dugas M, Trottier MÈ, Chipenda
Dansokho S, Vaisson G, Provencher T, Colquhoun
H, et al. Involving members of vulnerable popula-
tions in the development of patient decision aids: A
mixed methods sequential explanatory study. BMC
Med Inform Decis Mak [Internet]. 2017;17(1):1–
11. Disponible en: http://dx.doi.org/10.1186/
s12911-016-0399-8
31. Ward PR, Coffey C, Meyer S. Trust, choi-
ce and obligation: A qualitative study of enablers
of colorectal cancer screening in South Australia.
Sociol Heal Illn. 2015;37(7):988–1006.
32. Dy SM, Purnell TS. Key concepts relevant
to quality of complex and shared decision-making
in health care: A literature review. Soc Sci Med
[Internet]. 2012;74(4):582–7. Disponible en: http://
dx.doi.org/10.1016/j.socscimed.2011.11.015
33. Stone J. Race and healthcare disparities
overcoming vulnerability. Theor Med Bioeth.
2002;23(6):499–518.
34. Robertson R, Dixon A, Le Grand J. Patient
Choice in General Practice: The Implications of
Patient Satisfaction Surveys. J Health Serv Res
Policy [Internet]. 2008;13(2):67–72. Disponible
en: http://journals.sagepub.com/doi/10.1258/
jhsrp.2007.007055
35. Ghadi V, Naiditch M. Comment construi-
re la légitimité de la participation des usagers à des
problématiques de santé? Sante Publique (Paris).
2006;18(2):171–86.
36. Ells C. Preventing and resolving ethical
conflicts: more help for policy makers. Healthc
Manage Forum [Internet]. 2001;14(1):22–4.
Disponible
en:
http://dx.doi.org/10.1016/
S0840-4704(10)60388-2
37. Ko H. In science communication, why
does the idea of a public deficit always return?
Public Underst Sci. 2016;25(4):460–4.
38. Lopes E, Street J, Carter D, Merlin T.
Involving patients in health technology funding
decisions: Stakeholder perspectives on processes
used in Australia. Heal Expect. 2016;19(2):331–44.
39. Goold SD. Allocating health care: cost-uti-
lity analysis, informed democratic decision making,
or the veil of ignorance? J Health Polit Policy
Law [Internet]. 1996;21(1):69–98. Disponible en:
http://www.ncbi.nlm.nih.gov/pubmed/8708343
40. Callahan R, Darzi A. Analysis & commen-
tary: Five policy levers to meet the value challenge
Astorga-Pinto S.
in cancer care. Health Aff. 2015;34(9):1563–8.
41. Abraham J, Sheppard J. Democracy,
Technocracy, and the Secret State of Medicines
Control : Expert and Nonexpert Perspectives
Author ( s ): John Abraham and Julie Sheppard.
Sage Publications, Inc. 2017;22(2):139–67.
42. Facey K, Boivin A, Gracia J, Hansen HP,
Lo Scalzo A, Mossman J, et al. Patients’ perspec-
tives in health technology assessment: A route to
robust evidence and fair deliberation. Int J Technol
Assess Health Care. 2010;26(3):334–40.
43. Thomas R, Glasziou P, Rychetnik L,
Mackenzie G, Gardiner R, Doust J. Deliberative
democracy and cancer screening consent: A ran-
domised control trial of the effect of a commu-
nity jury on men’s knowledge about and inten-
tions to participate in PSA screening. BMJ Open.
2014;4(12):1–8.
44. Carman KL, Maurer M, Mangrum R,
Yang M, Ginsburg M, Sofaer S, et al. Understanding
An Informed Public; Views On The Role Of
Evidence In Making Health Care Decisions. Heal
Aff [Internet]. 2016;35(4):566–74. Disponible en:
http://dx.doi.org/10.1377/hlthaff.2015.1112
45. Hodgetts K, Hiller JE, Street JM, Carter D,
Braunack-Mayer AJ, Watt AM, et al. Disinvestment
policy and the public funding of assisted reproduc-
tive technologies: Outcomes of deliberative enga-
gements with three key stakeholder groups. BMC
Health Serv Res. 2014;14(1).
46. Weeks WB, Kotzbauer GR, Weinstein
JN. Using Publicly Available Data to Construct
a Transparent Measure of Health Care Value: A
Method and Initial Results. Milbank Q [Internet].
2016;94(2):314–33. Disponible en: http://www.
ncbi.nlm.nih.gov/pubmed/27265559%0Aht-
tp://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=PMC4911724%0Ahttp://doi.wiley.
com/10.1111/1468-0009.12194
47. Williams A. Thinking about equity in heal-
th care. J Nurs Manag. 2005;13(5):397–402.
48. Kolasa K, Dohnalik J, Borek E,
Siemiatkowski M, Ścibiorski C. The paradox of
public participation in the healthcare in Poland -
What citizens want, and what they think. Health
Policy (New York). 2014;118(2):159–65.
49. Douglas CMW, Wilcox E, Burgess M,
Lynd LD. Why orphan drug coverage reimbur-
sement decision-making needs patient and pu-
blic involvement. Health Policy (New York).
2015;119(5):588–96.
68